IRESSA*
- Gefitinib - @ - Epidermal Growth Factor Receptor Inhibitors - Antineoplastic Agents- (Feb 2004)
Compositions:
Gefitinib- mg,
List of Related Indications:
Gefitinib- mg,
- For the treatment of Patients with metastatic Non-Small Cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutation as detected by an FDA -approved test
Strength | Rate | Packing Style |
---|---|---|
mg | 0.00 | unit |